You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)上半年純利預降35%–45%
格隆匯 07-24 18:45

格隆匯 7 月 24日丨東陽光藥(01558.HK)公佈,預期集團截至2020年6月30日止半年度的公司權益股東應占溢利將較截至2019年6月30日止半年度減少約35%–45%。

公司權益股東應占溢利的預期減少主要由於在2020年上半年,受新型冠狀病毒肺炎疫情影響,中國國內人口流動性降低,醫院的診療活動數量、處方量及藥品銷量也隨之下降。集團核心產品可威(磷酸奧司他韋)為主要於等級醫院銷售的處方藥,其銷售量亦受新冠肺炎疫情影響而下降。

集團在疫情期間遵守國家的相關規定,保障員工就業,併為保證員工健康安全、正常復工復產而投入了一定額度的疫情防控費用;並且積極承擔社會責任,向社會捐贈款物。同時,集團亦持續貫徹產品學術推廣工作,為現有品種及即將上市品種在2020年下半年的銷售作準備。集團一直密切關注市場狀況並調整商業策略及運作以減少對業績的負面影響,包括拓展醫院外銷售渠道及推動新產品的上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account